This is so because the sensitivity of BerEP4 for RCC is quite low.[9] Hence, the panel of immunocytochemistry utilized in differentiation of adenocarcinoma and mesothelial cells (BerEP4, B72.3 and calretinin) would not assist in the same distinction with regards to RCC. The gene discussed is EPCAM; the disease is renal cell carcinoma.